Sino Biopharmaceutical Statistics

Total Valuation

SBHMY has a market cap or net worth of 10.37 billion. The enterprise value is 11.14 billion.

Market Cap	10.37B
Enterprise Value	11.14B

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Sep 11, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.36%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.84B

Valuation Ratios

The trailing PE ratio is 21.63 and the forward PE ratio is 22.54.

PE Ratio	21.63
Forward PE	22.54
PS Ratio	2.62
PB Ratio	1.77
P/TBV Ratio	2.46
P/FCF Ratio	13.39
P/OCF Ratio	11.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.98, with an EV/FCF ratio of 14.38.

EV / Earnings	23.24
EV / Sales	2.85
EV / EBITDA	11.98
EV / EBIT	14.46
EV / FCF	14.38

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.

Current Ratio	1.26
Quick Ratio	1.11
Debt / Equity	0.23
Debt / EBITDA	1.39
Debt / FCF	1.72
Interest Coverage	19.66

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 7.02%.

Return on Equity (ROE)	11.82%
Return on Assets (ROA)	5.62%
Return on Invested Capital (ROIC)	7.02%
Return on Capital Employed (ROCE)	12.65%
Revenue Per Employee	162,220
Profits Per Employee	19,668
Employee Count	24,379
Asset Turnover	0.45
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.67% in the last 52 weeks. The beta is 0.71, so SBHMY's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+31.67%
50-Day Moving Average	8.18
200-Day Moving Average	14.65
Relative Strength Index (RSI)	57.08
Average Volume (20 Days)	822

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SBHMY had revenue of 3.95 billion and earned 479.49 million in profits. Earnings per share was 0.03.

Revenue	3.95B
Gross Profit	3.22B
Operating Income	794.79M
Pretax Income	723.03M
Net Income	479.49M
EBITDA	944.33M
EBIT	794.79M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 2.03 billion in cash and 1.33 billion in debt, giving a net cash position of 699.73 million.

Cash & Cash Equivalents	2.03B
Total Debt	1.33B
Net Cash	699.73M
Net Cash Per Share	n/a
Equity (Book Value)	5.86B
Book Value Per Share	0.24
Working Capital	702.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 906.29 million and capital expenditures -131.54 million, giving a free cash flow of 774.76 million.

Operating Cash Flow	906.29M
Capital Expenditures	-131.54M
Free Cash Flow	774.76M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 20.10% and 12.12%.

Gross Margin	81.51%
Operating Margin	20.10%
Pretax Margin	18.28%
Profit Margin	12.12%
EBITDA Margin	23.88%
EBIT Margin	20.10%
FCF Margin	19.59%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.38%.

Dividend Per Share	0.13
Dividend Yield	1.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.76%
Buyback Yield	2.36%
Shareholder Yield	3.74%
Earnings Yield	4.62%
FCF Yield	7.47%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 14, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Aug 14, 2020
Split Type	Forward
Split Ratio	1.5

Scores

SBHMY has an Altman Z-Score of 2.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.75
Piotroski F-Score	n/a